Detailed price information for Corbus Pharmaceuticals Hldgs Inc (CRBP-Q) from The Globe and Mail including charting and trades.

This browser is no longer supported at MarketWatch. For the best MarketWatch.com experience, please update to a modern browser.

Pelareorep initiates a pro-inflammatory tumor microenvironment (TME) and induces innate and adaptive immune responses New ...

When Columbia neurologist and scientist Neil Shneider speaks to his ALS patients who volunteer for experimental therapies, he's unwaveringly honest.

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

On the surface, Piper Rockelle’s massively popular YouTube channel was glossy, fun and kid friendly. Starting when Piper was 11, her account featured videos of her and her posse of tween ...

Fermenta Biotech Limited, a leading player in the field of nutritional ingredients and food fortification, is pleased to announce that it has received the Letter Of Approval (LOA) by the Global ...

FRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other metabolic ...

Radiation sterilization technology destroys the DNA and cellular structures of bacteria and microorganisms using ...

Shares of Catalyst Pharmaceuticals Inc. CPRX rose 1.97% to $23.83 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP rising ...

At this time, I would like to welcome everyone to the Amylyx Pharmaceuticals First Quarter Earnings Conference Call. All participants will be in a listen-only mode. After today’s presentation ...

In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other worst blue chip stocks to buy. As per Niamh Brodie-Machura, Co-Chief ...